hCAII-IN-9

CAS No. 2878477-18-8

hCAII-IN-9( —— )

Catalog No. M36504 CAS No. 2878477-18-8

hCAII-IN-9 is a potent carbonic anhydrase inhibitor with IC50 values of 1.18 μM for hCA II, 0.17 μM for hCA IX, and 2.99 μM for hCA XII. It is not blood-brain barrier permeable.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 59 In Stock
10MG 86 In Stock
25MG 145 In Stock
50MG 216 In Stock
100MG 310 In Stock
200MG 454 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    hCAII-IN-9
  • Note
    Research use only, not for human use.
  • Brief Description
    hCAII-IN-9 is a potent carbonic anhydrase inhibitor with IC50 values of 1.18 μM for hCA II, 0.17 μM for hCA IX, and 2.99 μM for hCA XII. It is not blood-brain barrier permeable.
  • Description
    hCAII-IN-9 is a potent carbonic anhydrase inhibitor with IC50s of 1.18 μM (hCA II), 0.17 μM (hCA IX), and 2.99 μM (hCA XII), respectively. hCAII-IN-9 has no blood-brain barrier permeability.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    Carbonic Anhydrase
  • Recptor
    Carbonic Anhydrase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2878477-18-8
  • Formula Weight
    417.89
  • Molecular Formula
    C15H16ClN3O5S2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    S(N)(=O)(=O)C1=C(NC(=O)C2=CC(C)=CC(C)=C2)C=C(Cl)C(S(N)(=O)=O)=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Hussain Z, et al. Synthesis and Evaluation of Amide and Thiourea Derivatives as Carbonic Anhydrase (CA) Inhibitors. ACS Omega. 2022 Dec 6;7(50):47251-47264. ?
molnova catalog
related products
  • Mafenide hydrochlori...

    Mafenide hydrochloride is a sulfonamide-type medication used as an antibiotic.

  • Brinzolamide

    Brinzolamide is a highly specific, non-competitive, reversible carbonic anhydrase inhibitor.

  • Methazolamide

    Methazolamide is a carbonic anhydrase inhibitor used to treat glaucoma.